Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002383517 | SCV002699639 | pathogenic | Hereditary cancer-predisposing syndrome | 2020-09-16 | criteria provided, single submitter | clinical testing | The p.Y454* pathogenic mutation (also known as c.1362C>G), located in coding exon 14 of the RB1 gene, results from a C to G substitution at nucleotide position 1362. This changes the amino acid from a tyrosine to a stop codon within coding exon 14. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Laboratorio de Genetica e Diagnostico Molecular, |
RCV003138241 | SCV003807451 | likely pathogenic | Retinoblastoma | 2022-04-27 | criteria provided, single submitter | clinical testing | ACMG classification criteria: PVS1 very strong, PM2 moderated |